AORT vs AXGN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

AORT

38.7
AI Score
VS
AORT Wins

AXGN

33.4
AI Score

Investment Advisor Scores

AORT

39score
Recommendation
AVOID NEW MONEY

AXGN

33score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric AORT AXGN Winner
Forward P/E 30.3951 109.8901 AORT
PEG Ratio 181.5 99.0419 AXGN
Revenue Growth 9.2% 26.2% AXGN
Earnings Growth 0.0% 300.0% AXGN
Tradestie Score 38.7/100 33.4/100 AORT
Profit Margin -3.6% -12.0% AORT
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED AXGN

Relative Price Performance (Last 90 Days)

AORT 1M: -6.1% · 3M: -28.5% AXGN 1M: +37.1% · 3M: +2.5%

Current Technical Phase

AORT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 40

RSI (14): 39.5 · Price: $20.47

AXGN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 69

RSI (14): 69.4 · Price: $50.89

Fundamentals Snapshot

Metric AORT AXGN
Market Cap — —
Forward P/E 39.4 72.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.3%
Gross Margin 0.6% 0.7%
Operating Margin 0.0% 0.0%
EPS -0.36 -0.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AORT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.